Neurology ReviewsNo serious CV risks for elderly after Pfizer COVID-19 vaccineDecember 2, 2021COVID-19 UpdatesStroke
Neurology ReviewsCOVID-19 antibody drug likely works against Omicron, companies say December 2, 2021COVID-19 Updates
Neurology ReviewsTen changes that could keep clinicians in the workforce in a pandemicDecember 2, 2021Business of MedicineCOVID-19 Updates
Neurology ReviewsModerna warns of material drop in vaccine efficacy against OmicronDecember 1, 2021COVID-19 Updates
Neurology ReviewsFDA panel backs first pill for COVID-19 by a small marginNovember 30, 2021COVID-19 Updates
Neurology ReviewsMerck’s COVID-19 pill may be less effective than first hopedNovember 30, 2021COVID-19 Updates
Neurology ReviewsFueling an ‘already raging fire’: Fifth COVID surge approachesNovember 24, 2021COVID-19 Updates
Neurology ReviewsHeadache is a common post–COVID-19 complaintNovember 24, 2021Headache & MigraineCOVID-19 Updates
Neurology ReviewsCOVID surge in Europe: A preview of what’s ahead for the U.S.?November 22, 2021COVID-19 Updates
Neurology ReviewsCDC unveils mental health protection plan for health care workersNovember 22, 2021Business of MedicineCOVID-19 Updates
Neurology ReviewsCDC: Thirty percent of hospital workers in U.S. still unvaccinatedNovember 19, 2021COVID-19 Updates
